Yoshiko Naito
Overview
Explore the profile of Yoshiko Naito including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
147
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamamoto T, Hayashida T, Masugi Y, Oshikawa K, Hayakawa N, Itoh M, et al.
Cancer Res
. 2024 Feb;
84(7):1065-1083.
PMID: 38383964
Significance: PRMT1 promotes chemoresistance in TNBC by methylating metabolic enzymes PFKFB3, PKM2, and PHGDH to augment de novo fatty acid synthesis, indicating that targeting this axis is a potential treatment...
2.
Shigeta K, Hasegawa M, Hishiki T, Naito Y, Baba Y, Mikami S, et al.
EMBO J
. 2023 Jan;
42(4):e110620.
PMID: 36637036
Drug resistance contributes to poor therapeutic response in urothelial carcinoma (UC). Metabolomic analysis suggested metabolic reprogramming in gemcitabine-resistant urothelial carcinoma cells, whereby increased aerobic glycolysis and metabolic stimulation of the...
3.
Tanaka T, Sakai R, Choi I, Tsukada J, Sasaki H, Naito Y, et al.
Sci Rep
. 2022 Feb;
12(1):3124.
PMID: 35210509
We conducted a multicenter prospective study on whether a comprehensive geriatric assessment (CGA) can predict the adverse events (AEs) of chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)....
4.
Mizota T, Hishiki T, Shinoda M, Naito Y, Hirukawa K, Masugi Y, et al.
J Clin Biochem Nutr
. 2022 Jan;
70(1):54-63.
PMID: 35068682
The liver has been thought to protect against oxidative stress through mechanisms involving reduced glutathione (GSH) that consumes high-energy phosphor-nucleotides on its synthesis. However, hepatoprotective mechanisms in acute liver failure...
5.
Yano C, Tominaga M, Naito Y, Tokunaga Y, Kinoshita T, Sasaki J, et al.
J Infect Chemother
. 2021 Dec;
28(3):426-433.
PMID: 34933786
Introduction: Despite the growing population of long-term survivors with human immunodeficiency virus 1 (HIV) exhibiting asthma-like features worldwide, the pathogenesis underlying airway hyperresponsiveness (AHR) and airway inflammation remains unclear. We...
6.
Honda K, Hishiki T, Yamamoto S, Yamamoto T, Miura N, Kubo A, et al.
Redox Biol
. 2021 Jun;
44:102028.
PMID: 34087755
No abstract available.
7.
Honda K, Hishiki T, Yamamoto S, Yamamoto T, Miura N, Kubo A, et al.
Redox Biol
. 2021 Mar;
41:101926.
PMID: 33752108
Chemosensitivity to cisplatin derivatives varies among individual patients with intractable malignancies including ovarian cancer, while how to unlock the resistance remain unknown. Ovarian cancer tissues were collected the debulking surgery...
8.
Koike N, Kota R, Naito Y, Hayakawa N, Matsuura T, Hishiki T, et al.
Commun Biol
. 2020 Aug;
3(1):450.
PMID: 32807853
Under hypoxic conditions, nitroimidazoles can replace oxygen as electron acceptors, thereby enhancing the effects of radiation on malignant cells. These compounds also accumulate in hypoxic cells, where they can act...
9.
Ishii H, Azuma K, Kawahara A, Kinoshita T, Matsuo N, Naito Y, et al.
Thorac Cancer
. 2020 Feb;
11(4):950-955.
PMID: 32061060
Background: CD73 induces the dephosphorylation of adenosine monophosphate converting it to adenosine, enabling malignancies to escape from immune surveillance. Although CD73 overexpression has been reported to be a poor prognostic...
10.
Ishii H, Azuma K, Sakai K, Naito Y, Matsuo N, Tokito T, et al.
Sci Rep
. 2020 Jan;
10(1):691.
PMID: 31959859
Third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) were developed to target the EGFR T790M resistance mutation in non-small cell lung cancer (NSCLC) patients resistant to first- or...